ANIP - ANI Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$91.00
DETAILS
HIGH:
$91.00
LOW:
$91.00
MEDIAN:
$91.00
CONSENSUS:
$91.00
UPSIDE:
12.29%
About ANI Pharmaceuticals, Inc. (https://www.anipharmaceuticals.com)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Nikhil Lalwani | President, Chief Executive Officer & Director | 1978 | $2,429,909 USD |
| Christopher K. Mutz | Senior Vice President & Head of Rare Disease | 1972 | $1,266,375 USD |
| Stephen Carey | Senior Vice President of Finance & Chief Financial Officer | 1971 | $1,121,543 USD |
| Ori Gutwerg | Senior Vice President of Generics | 1975 | $964,148 USD |
| Meredith W. Cook | Senior Vice President, General Counsel & Corporate Secretary | 1974 | $860,808 USD |
| Chad Gassert | Senior Vice President of Corporate Development & Strategy | 1976 | $849,711 USD |
| Elizabeth Powell | Chief Compliance Officer & Head of Legal of Rare Disease | – | – |
| Krista L. Davis | Senior Vice President & Chief Human Resources Officer | 1973 | – |
| Mary Pao | Chief Medical Officer | – | – |
| Muthusamy Shanmugam | Head of R&D, Chief Operating Officer of New Jersey Operations & Director | 1968 | – |
| Thomas Andrew Rowland | Senior Vice President & Head of Established Brands | 1967 | – |